Author

S. Jaime-Figueroa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

C. M. Crews· 2 shared J. Hines· 1 shared K. . T. G. Samarasinghe· 1 shared K. Dai· 1 shared K. Samarasinghe· 1 shared L. Vogt· 1 shared N. Rosen· 1 shared S. Alabi· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

C. M. Crews

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivOct 12, 2020

Targeted Degradation of Transcription Factors by TRAFTACs: Transcription Factor Targeting Chimeras

K. Samarasinghe, S. Jaime-Figueroa, K. Dai…·C. M. Crews

This study develops TRAFTACs, chimeric oligonucleotides that degrade transcription factors via proteasomal pathway, and demonstrates their effectiveness on NF-κB and brachyury.

DOI 10.1016/j.chembiol.2021.03.011

experimental assaydrug response / drug discovery

𝕏 PostBluesky

Cancer BiologybioRxivAug 10, 2020

Mutant-selective Degradation by BRAF-targeting PROTACs

S. Alabi, S. Jaime-Figueroa, Z. Yao…·C. M. Crews

This study develops BRAF-targeting PROTACs that degrade all BRAF mutants at sub-nanomolar concentrations while sparing wild-type RAF family members, showing in vivo efficacy and mechanistic insights.

DOI 10.1038/s41467-021-21159-7

humanexperimental assay

𝕏 PostBluesky